Balyasny Asset Management L.P.

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1218710 Chicago, IL

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$23,511,009

-$21,789,109 QoQ

Shares Held

1,279,859

-44.7% QoQ

Ownership

1.13%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#29

of 215 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. VRDN ranks #34 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,511,009	1,279,859	-44.7%	Shares	Sole	2026-08-14
2026-03-31	$45,300,118	2,315,957	+359.6%	Shares	Sole	2026-05-15
2025-12-31	$15,680,372	503,868	+148.4%	Shares	Sole	2026-02-17
2025-09-30	$4,376,877	202,821	+55.2%	Shares	Sole	2025-11-14
2024-12-31	$2,505,921	130,721	-61.4%	Shares	Sole	2025-02-14
2024-09-30	$7,714,274	339,089	+722.8%	Shares	Sole	2024-11-14
2023-12-31	$897,640	41,214	+195.0%	Shares	Sole	2024-02-14
2023-09-30	$214,284	13,969	-95.4%	Shares	Sole	2023-11-14
2022-12-31	$8,895,963	304,552	+79.6%	Shares	Sole	2023-02-14
2022-09-30	$3,477,039	169,529	+939.9%	Shares	Other	2022-11-15
2022-03-31	$301,442	16,303	-86.4%	Shares	Sole	2022-05-16
2021-06-30	$2,185,252	119,478	-0.1%	Shares	Sole	2021-08-16
2021-03-31	$1,998,114	119,576	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.